Treace Medical Concepts Inc at Morgan Stanley Global Healthcare Conference Transcript
Thanks everyone for joining us this morning. I'm Drew Ranieri, one of the medical device analyst here at Morgan Stanley. It's my pleasure today to have Treace Medical with us. And from the company, we have CEO, John Treace; CFO, Mark Hair; and Investor Relations, Julie Dewey. So before we get started, just a brief disclaimer. About full important disclosures, see morganstanley.com/researchdisclosures.
Questions & Answers
With that, let's kind of get into the discussion. And maybe first, let's talk about the market opportunity for Treace, John. You've mentioned that before that [extremities] is one of the faster-growing markets in orthopedics, growing high-single-digits. So a couple of questions here. On the procedure side, we got 450,000 annual procedure opportunity. So maybe just talk about what you see in terms of that underlying market growth? And then how you're deploying patients off the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |